Figures & data
Box 1 Multiple Sclerosis in Qatar
Figure 1 Consensus ratings of the efficacy and safety of disease-modifying therapies (DMTs) used in the management of relapsing multiple sclerosis. Expert neurologists (the authors) rated safety and efficacy on a Likert scale of 1 (least favourable) to 7 (most favourable). Average ratings are shown here.
![Figure 1 Consensus ratings of the efficacy and safety of disease-modifying therapies (DMTs) used in the management of relapsing multiple sclerosis. Expert neurologists (the authors) rated safety and efficacy on a Likert scale of 1 (least favourable) to 7 (most favourable). Average ratings are shown here.](/cms/asset/160625e6-8fa1-4871-9d97-a3aa12e06345/dnnd_a_12299032_f0001_c.jpg)
Table 1 Summary of Recommendations
Table 2 Factors Influencing the Suitability of Cladribine Tablets for Different Subgroups of Patients with Relapsing MS